FGFR inhibitors (Exelixis)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameFGFR inhibitors (Exelixis)

Drug Alias NameEXEL-4832EXEL-6009EXEL-7524EXEL-9291EXEL-2825 +[12]

ClassificationSmall molecules

Mechanisms of ActionFibroblast growth factor receptor 1 antagonistsAnticancer protein kinase inhibitorsFibroblast growth factor receptor 2 antagonists +[4]

TargetsFibroblast growth factor receptor 1Fibroblast growth factor receptor 3Fibroblast growth factor receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesExelixis Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesExelixis Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A